These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10951656

  • 21. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
    Lalonde RL, Wagner JA.
    Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process.
    Bertino JS, Greenberg HE, Reed MD, American College of Clinical Pharmacology.
    J Clin Pharmacol; 2007 Apr; 47(4):418-22. PubMed ID: 17389550
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Follow the dosage instructions when the dose is to be adjusted for renal function].
    Ståhle L.
    Lakartidningen; 2007 Apr; 110(47):2121. PubMed ID: 24437104
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Drug dosage adjustments according to renal function at hospital discharge.
    van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA.
    Ann Pharmacother; 2006 Apr; 40(7-8):1254-60. PubMed ID: 16804098
    [Abstract] [Full Text] [Related]

  • 35. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC, Cross JT.
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract] [Full Text] [Related]

  • 36. Positron emission tomography for use in microdosing studies.
    Wagner CC, Müller M, Lappin G, Langer O.
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of methadone.
    Lugo RA, Satterfield KL, Kern SE.
    J Pain Palliat Care Pharmacother; 2005 Jan; 19(4):13-24. PubMed ID: 16431829
    [Abstract] [Full Text] [Related]

  • 38. Individualization of drug dosage--past, present and future.
    Thomson AH.
    Med Monatsschr Pharm; 2003 May; 26(5):150-2. PubMed ID: 12784502
    [Abstract] [Full Text] [Related]

  • 39. [Drugs, drug forms and intake conditions: pharmacokinetic selection criteria and consequences for dosage recommendations].
    Ahr G.
    Pharm Unserer Zeit; 1996 Jul; 25(4):197-8. PubMed ID: 8927636
    [No Abstract] [Full Text] [Related]

  • 40. Case report: adverse drug reactions in unrecognized kidney failure.
    Farrell B, Pottie K, Hogg W.
    Can Fam Physician; 2004 Oct; 50():1385-7. PubMed ID: 15526875
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.